medigraphic.com
ISSN 0185-6014 (Impreso)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2019, Número 2

<< Anterior Siguiente >>

Rev Mex Patol Clin Med Lab 2019; 66 (2)


Interpretación clínica de la citometría hemática en el paciente grave. El enfoque del intensivista

Monares-Zepeda E, Ríos-Ayala MA, Garza-De la Maza A

Idioma: Español
Referencias bibliográficas: 28
Paginas: 100-106
Archivo PDF: 268.19 Kb.


RESUMEN

La citometría hemática es uno de los estudios de laboratorio más solicitados en pacientes hospitalizados y el primer examen al que se enfrenta el clínico en la evaluación diagnóstica. En terapia intensiva son múltiples las indicaciones para solicitar una citometría hemática y de manera frecuente el paciente grave tiene numerosas anormalidades, resultado de la respuesta inmunoinflamatoria y compromiso orgánico múltiple, pero más allá de la evaluación de la anemia, trombocitopenia y/o leucocitosis en el enfermo crítico, el médico debe analizar de forma dirigida algunos marcadores que informan sobre el estado de la enfermedad al momento de la valoración, en particular de la cronicidad, severidad y pronóstico de estas condiciones graves, lo que ayuda a la toma de decisiones diagnóstico-terapéuticas. Por lo anterior, hacemos una revisión de los aspectos más importantes que deben ser resaltados en el análisis de la citometría hemática desde el punto de vista de un intensivista, sobre todo en el manejo de casos graves, haciendo énfasis en su utilidad clínica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Jaime-Pérez JC, Gómez-Almaguer D. Hematología. La sangre y sus enfermedades. 4 edición. Ciudad de México. McGraw-Hill 2015.

  2. Hunziker S, Stevens J, Howell MD. Red cell distribution width and mortality in newly hospitalized patients. Am J Med. 2012; 125: 283-291.

  3. Liu X, Shen Y, Wang H, Ge Q, Fei A, Pan S. Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: a prospective observational study. Mediators Inflamm. 2016; 2016: 8191254.

  4. Allen LA, Felker GM, Mehra MR, Chiong JR, Dunlap SH, Ghali JK et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Cardiac Fail. 2010; 16: 230-238.

  5. Lowsby R, Gomes C, Jarman I, Lisboa P, Nee PA, Vardhan M et al. Neutrophil to lymphocyte count ratio as an early indicator of blood stream infection in the emergency department. Emerg Med J. 2015; 32 (7): 531-534.

  6. Sánchez-Chaparro MA, Calvo-Bonacho E, Gonzalez-Quintela A, Cabrera M, Sainz JC, Fernandez-Labandera C et al. Higher red blood cell distribution width is associated with the metabolic syndrome: results of the Ibermutuamur Cardiovascular Risk assessment study. Diabetes Care. 2010; 33: e40.

  7. Wang F, Pan W, Pan S, Ge J, Wang S, Chen M. Red cell distribution width as a novel predictor of mortality in ICU patients. Ann Med. 2010; 43: 40-46.

  8. Cavusoglu E, Chopra V, Gupta A, Battala VR, Poludasu S, Eng C et al. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol. 2010; 141: 141-146.

  9. Braun E, Domany E, Kenig Y, Mazor Y, Makhoul BF, Azzam ZS. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Crit Care (London). 2011; 15: R194.

  10. Hunziker S, Celi LA, Lee J, Howell MD. Red cell distribution width improves the simplified acute physiology score for risk prediction in unselected critically ill patients. Crit Care. 2012; 16 (3): R89.

  11. Liu H, Liu G, Tian Z. Changes in blood lymphocytes in sepsis patients. Zhongua Wei Zhong Bing Ji Jiu Ti Xue. 2014; 26 (3): 148-152.

  12. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001; 102 (1): 5-14.

  13. Riché F, Gayat E, Barthélémy R, Le Dorze M, Matéo J, Payen D. Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock. Crit Care. 2015; 16 (19): 439.

  14. Naess A, Mo R, Nilssen SS, Eide GE, Sjursen H. Infections in patients hospitalized for fever as related to duration and other predictors at admittance. Infection. 2014; 42: 485-492.

  15. Naess A, Nilssen SS, Mo R, Eide GE, Sjursen H. Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever. Infection. 2017; 45 (3): 299-307.

  16. Gürol G, Ciftci IH, Terzi HA, Atasoy AR, Ozbek A, Köroğlu M. Are there standardized cutoff values for neutrophil-lymphocyte ratios in bacteremia or sepsis? J Microbiol Biotechnol. 2015; 25: 521-525.

  17. Tannverdi H, Örnek T, Erboy F, Altinsoy B, Uygur F, Atalay F et al. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD. Wien Klin Wochenschr. 2015; 127: 756-763.

  18. Zheng CF, Liu WY, Zeng FF et al. Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury. Crit Care. 2017; 21(1): 238. doi: 10.1186/s13054-017-1821-z.

  19. Bekdas M, Ozturk H. Platelet-to-lymphocyte ratio in diagnosis of acute complicated appendicitis in childhood. J Clin Anal Med. 2017; 8 (4): 299-301.

  20. Diordjevic D, Rondovic G, Surbatovic M et al. Neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume-to-platelet count ratio as biomarkers in critically ill and injured patients: which ratio to choose to predict outcome and nature of bacteremia? Mediators Inflamm. 2018; 2018: 3758068.

  21. Oh GH, Chung SP, Park YS et al. Mean platelet volume to platelet count ratio as a promising predictor of early mortality in severe sepsis. Shock. 2017; 47 (3): 323-330.

  22. Gao Y, Li Y, Yu X et al. The impact of various platelet indices as prognostic markers of septic shock. PLoS One. 2014; 9: e103761. doi: 10.1371/journal.pone.0103761.

  23. Kim CH, Kim SJ, Lee MJ et al. An increase in mean platelet volume from baseline is associated with mortality in patients with severe sepsis or septic shock. PLoS One. 2015; 10 (3): e0119437.

  24. Zampieri FG, Ranzani OT, Sabatoski V et al. An increase in mean platelet volume after admission is associated with higher mortality in critically ill patients. Ann Intensive Care. 2014; 4: 20.

  25. Sadaka F, Donnelly PL, Griffin MT, O’Brien J, Lakshmanan R. Mean platelet volume is not a useful predictor of mortality in septic shock. J Blood Disorders Transf. 2014; 5: 2.

  26. Guclu E, Durmaz Y, Karabay O. Effect of severe sepsis on platelet count and their indices. Afr Health Sci. 2013; 13 (2): 333-338.

  27. Ates S, Oksuz H, Dogu B, Bozkus F, Ucmak H, Yanıt F. Can mean platelet volume and mean platelet volume/platelet count ratio be used as a diagnostic marker for sepsis and systemic inflammatory response syndrome? Saudi Med J. 2015; 36 (10): 1186-1190.

  28. Sánchez CA, Navarro AJ, Monares ZE et al. Utilidad del volumen plaquetario medio para descartar sepsis. Rev Asoc Mex Med Crit y Ter Int. 2016; 30 (2): 87-94.




2020     |     www.medigraphic.com